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1.  Introduction 
1.1. Background 
Millennium Development Goals 
In 2000 world leaders established the so called Millennium Development Goals, 
which along with seven other goals postulated a reduction in child mortality by 
two-thirds to be achieved by 2015. (United Nations, 2015a) 
Although this ambitious target was not achieved the estimated annual deaths of 
children under 5 years of age were reduced by 53% to around 6 million deaths 
worldwide in 2015. 
Most of these under-five deaths occur in developing countries with about half of 
them (approx. 3 million) occurring in Sub-Saharan Africa with 83 per 1,000 
children dying before their fifth birthday. (United Nations, 2015a) 
The new Sustainable Development Goals, established in 2015 foresee a 
worldwide reduction to no more than 25 per 1,000 deaths of children under 5 by 
2030. (United Nations, 2015b) To achieve this, it is imperative to take a closer 
look at what causes child morbidity and mortality worldwide.  
Seeing as the percentage of children under five dying prematurely varies greatly 
throughout the world, it is only natural to conclude that the causes also vary. In a 
multi-centric study on “global, regional and national causes of under-five mortality 
rates” by L. Liu et al., 2016, the main causes of child mortality in developing 
countries were found to be neonatal deaths (45%), pneumonia (13%) and 
diarrhoea (9%).   
Diarrhoeal disease causes more than half a million deaths of children under 5 
years of age each year, with again most of these deaths occurring in Sub-
Saharan Africa, as illustrated in Figure 1. This highlights diarrhoea’s role as one 
of the most important infectious diseases that needs to be addressed if child 




Figure 1: Diarrhoea mortality rates worldwide for children younger than 5 in 2015 (Figure by Troeger et al., 
2017)  
 
Diarrhoea is the fourth most prevalent cause of death globally in children and 
adolescents aged 19 years or younger in 2017, with malaria as one of the most 
notable tropical diseases only ranking sixth (Roba et al., 2017).  
Nearly every child throughout the world suffers from diarrhoea at one point or 
another. It is therefore often underestimated in its potential to pose a serious 
threat to a child’s short- and long-term health and is often seen as a passing 
inconvenience without further relevance, however, newer studies have shown 
that especially in low-resource settings, where children tend to experience more 
episodes of diarrhoea, the consequences for child health as well as development 
(Checkley et al., 2008) and survival cannot be dismissed (Troeger et al., 2017). 
 
1.2. The physiology behind diarrhoea 
Diarrhoea is defined by the WHO as the passage of three or more liquid stools 
during the course of 24 hours. (World Health Organization (WHO), 2013b) The 
emphasis lies on the consistency, allowing for individual variations in what is 




Physiology of digestion 
While the upper intestinal tract usually secretes large amounts of fluids, to ease 
digestion as well as the faeces’ passage, approximately 76% of the fluid is 
absorbed in the ileum and another 22% (Gekle, 2018) in the colon resulting in 
formed stool with a consistency ranging from soft to hard, that is then excreted. 
Stool consists mostly of indigestible parts of foodstuffs, as well as bacterial flora 
that is discharged and other waste products.  
While consistency and frequency can vary greatly due to nutritional factors, 
physical or psychological state and the bacterial flora of the individual, an 
increase in unformed stool secretion as observed in diarrhoeal disease is always 
a sign of an underlying pathology. 
Pathophysiology 
Diarrhoea as a symptom offers a great number of differential diagnoses, which 
are not limited to primary infections of the gut. Depending on the clinical 
presentation auto-immune diseases such as Celiac or Crohn’s disease, as well 
as ulcerative colitis or malabsorption due to food intolerance (e.g. lactose or 
fructose) need to be considered. It can also be a symptom of malignant growth in 
the digestive tract or present as part of an infectious disease that does not 
primarily target the gastro-intestinal system but causes the body to react with 
hypersecretion, for example malaria (Ashie et al., 2017; Weinberg et al., 1997) or 
measles (Schuster & Kreth, 2019). In the latter case diarrhoea may even be the 
initial symptom of the disease, while the other more characteristic symptoms like 
for example fever (malaria) or fever and rash (measles) manifest themselves 
later.  
An important aspect in the differential diagnoses of diarrhoeal disease is the 
patient’s age. While all of these diseases can occur no matter how old the patient 
is, the overall likelihood varies greatly. Chronic inflammatory bowel disease or 
malignant growth are for example generally only found in adults. 
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Since acute diarrhoea (symptoms present less than two weeks) and to a lesser 
extent even chronic diarrhoea most often originate from infections, I decided to 
focus my research on infectious diarrhoea.  
Acute or infectious diarrhoea, can be divided into three categories, secretory, 
invasive and penetrative diarrhoea, with distinct patho-mechanisms and 
causative agents. (Schmiedel, 2016)  
Secretory Diarrhoea 
Secretory diarrhoea means that the epithelial cells of the small intestine are 
induced to secrete more water than usual while the large intestine is not able to 
absorb the excess fluid sufficiently. The result is liquid to watery diarrhoea that 
continues even when no food is ingested. Common infectious agents causing this 
are Vibrio cholerae with the cholera toxin. 
Invasive Diarrhoea 
This type of diarrhoea originates in the colon. The bacteria invade the epithelial 
cells and destroy them, which leads to local inflammation and loss of function of 
the epithelial layer. The fluids secreted in the small intestine cannot be 
reabsorbed which combined with the inflammation causes mucoid and bloody 
diarrhoea. Typical pathogens in this category are Shigella spp., Entamoeba 
histolytica and EIEC (entero-invasive E.coli). 
Penetrative Diarrhoea 
Bacteria such as Salmonella enteritidis and Yersinia enterocolitica pass through 
the epithelial cells of the small intestine into the submucosa and Peyer-Plaques 
where they cause inflammation. The exact patho-mechanism causing diarrhoea 
is not clear, however, generally this type of diarrhoea presents with fever as an 
additional symptom.  
Irrespective of the underlying pathology, apart from the aforementioned change 
in stool consistency and frequency, children suffering from diarrhoea may present 
a multitude of different symptoms such as vomiting, loss of appetite or fatigue. 




exaggeration of or subsequent malnourishment. Studies have shown that 
children being hospitalised for severe malnutrition accompanied by diarrhoea 
have a much higher mortality rate than those without diarrhoea (Talbert et al., 
2012). 
In cases where diarrhoea persists over weeks and months, it may lead to stunting 
and in extreme cases to wasting, as well as an overall higher susceptibility to 
other infections (Checkley et al., 2008). 
 
1.3. Pathogens causing diarrhoea 
Many studies have been conducted in the last few decades on the epidemiology 
of diarrhoeal disease world-wide. The spectrum of pathogens found and deemed 
relevant in causing diarrhoeal disease has varied greatly depending on when and 
where the studies were conducted, depending on which age group was examined 
or whether the participants were afflicted with further illnesses, and last but not 
least, on which diagnostic methods were employed. Since outbreaks of diarrhoea 
have long been linked to low sanitation standards, which then lead to 
contaminated food or water, it is tempting to conclude that a country’s level of 
development, a marker of which can among others be its population’s access to 
safe drinking water (World Health Organization (WHO) & United Nation’s 
Children’s Fund (UNICEF), 2017), may be related to the number of diarrhoeal 
episodes experienced per person. It is however not possible to directly link 
hygiene and sanitation to morbidity and mortality, because there are many 
different variables involved (Crocker & Bartram, 2016).  
There are a number of pathogens that disrupt the digestive system and cause 
diarrhoea. Since the gut is host to a very complex microbiome where millions of 
bacteria co-exist by forming an intricate web of interdependence that generally 
regulates itself, every individual will react differently when exposed to a potential 
pathogen. Certain bacteria and viruses are obligate pathogens (e.g. Vibrio 
cholerae, Norovirus) and will always lead to a disruption in the function of the 
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digestive tract resulting in diarrhoea unless an immune response is quickly 
meditated in cases of re-exposure.  
It is not clear whether the spectrum of pathogens causing diarrhoeal disease 
varies between developed and developing countries. A comprehensive study 
comparing the pathogens most often responsible for under-five deaths in different 
countries and between high and low SDIs found similar rankings (with rotavirus 
always part of and Shigella spp. and cholera most often represented in the top 3 
and with C. diff. more significant in high SDI and Cryptosporidium spp. in low SDI 
countries) (Troeger et al., 2017), however, this does not necessarily mean that 
the spectrum of pathogens causing diarrhoea is similarly distributed, only that the 
same pathogens prove to be the most lethal  irrespective of a country’s SDI. 
One of the most recent and most relevant studies in this field is by any measure 
the GEMS (Global Enteric Multi-centre study). This study focused mainly on 
children below five years of age in several countries throughout Africa and Asia 
and used a case-control approach to determine which pathogens were mainly 
responsible for episodes of diarrhoea in their cohorts. In young children, 
diarrhoea was mostly attributed to rotavirus, Cryptosporidium spp., 
Enterotoxigenic E. coli (ETEC) and Shigella spp. (Kotloff et al., 2013). Upon re-
evaluation with more sensitive diagnostic methods, the ranking changed to 
Shigella spp., rotavirus, adenovirus, ETEC, Cryptosporidium spp., and 
Campylobacter spp. (J. Liu et al., 2016).  
The inclusion of Cryptosporidium spp. in the top 6 pathogens causing diarrhoea 
in children was at the time wholly unexpected. So far, this parasite had been 
considered of no importance in immune-competent individuals (Striepen, 2013). 
Aside from studies focusing on small children or travellers, it proves difficult to 
find comprehensive literature on causes of diarrhoea in the general population. 
Too little is known about the aetiology of diarrhoea in patients older than 5 and 
younger than 65, since aside from these age groups patients affected are not as 
likely to seek medical assistance (Wilson, 2005). Therefore, case numbers can 
only be assumed, and further identification of the underlying cause is seldomly 




1.4. Treatment principles 
The treatment of infantile diarrhoea should follow the WHO guidelines (World 
Health Organization (WHO), 2005) which postulate the use of oral rehydration 
solution (ORS) until diarrhoea cedes or in cases with severe dehydration 
intravenous fluids, additionally zinc supplementation for 10-14 days and 
continued feeding. The WHO warns against the use of antimicrobial agents 
unless bloody stools are reported, cholera is suspected or if the child suffers from 
a severe non-intestinal infection. Anti-motility drugs should generally not be 
administered to children below 5 years of age.  
This treatment approach is mostly symptomatic. So far when it comes to 
infectious diarrhoea there is hardly any direct approach to treating the underlying 





2. Aims of the project presented 
The aim of this pilot study was to determine the aetiology of childhood diarrhoea 
in Lambaréné and its immediate surroundings, with a special interest on the 
possible occurrence of Cryptosporidium spp.  
Additionally, patient’s symptoms were characterized and possible correlations 
between pathogenic agents identified and patient presentation were assessed. 
Furthermore, as part of the project, new diagnostic methods for Cryptosporidium 
spp. were established and evaluated. 
 
3. Cryptosporidium 
3.1. Biological aspects of the parasite 
Crypotsporidium is a parasite belonging to (the subkingdom of protozoa and) the 
phylum of apicomplexa and is thus related to Plasmodium and Toxoplasma. It 
has recently been classified as a gregarine instead of a coccidian parasite, which 
shows a change in perception of the parasite’s biology. (Clode et al., 2015)  
As opposed to other well-known apicomplexans Cryptosporidium shows a very 
reduced metabolism. It contains the apical complex, which is the defining feature 
for this phylum of parasites, but instead of some of the normally characteristic 
organelles for this phylum like the apicoplast, (a relict, formerly photosynthetic 
plastid) Cryptosporidium spp. has an extended pellicle, which increases the 
surface and the amount of micropores to access the readily available nutrients in 
the intestinal tract (Ryan et al., 2016).  
The parasite passes through its entire life cycle in one host, multiplying both 
sexually and asexually in the small intestine of the host and exiting through the 
large intestine in the form of hardy oocysts that are then ingested either by the 
same or another host. While this work focuses mainly on human infection, which 
is notably caused mainly by Cryptosporidium hominis or Cryptosporidium 




other subspecies have been found to infect animals, with the parasites following 
the same life cycle and mostly causing similar symptoms of infection. Groups of 
animals discovered to be susceptible are mostly mammalians, but also birds, 
where infection manifests in the respiratory tract and reptiles, in which illness is 
generally severe and usually proves to be fatal (O’Donoghue, 1995).  
Once a host has been infected and the parasite has reached a suitable mucous 
membrane (generally in the small intestine, although it has been shown that the 
parasite can also multiply in other parts of the body e.g. inside respiratory 
epithelial cells) the oocysts hatch and the sporozoites invade the epithelial cells 
where they develop into trophozoites and subsequently into meronts, which 
produce merozoites that then go on to infect new epithelial cells and replicate 
either asexually producing further merozoites or go on to reproduce sexually via 
differentiation into macro- and microgamonts and ending in the production of 





Figure 2: Cryptosporidium life cycle (Centers for Disease Control and Prevention et al., 2015b)1 
 
 
1 Disclaimer: The use of this figure does not constitute an endorsement or recommendation of 
this dissertation by the U.S. Government, Department of Health and Human Services, or Centers 





Cryptosporidium parvum and hominis are the two subtypes that are most often 
isolated in human cryptosporidiosis. At least 11 others have been isolated in a 
few cases (Squire & Ryan, 2017).  
Symptoms of Cryptosporidiosis include watery diarrhoea, stomach pain, 
moderate to severe dehydration, occasionally fever and other complaints 
associated with acute diarrhoea. In case of parasite persistence over months, 
additional symptoms may include substantial weight loss, failure to thrive in 
infants, stunting and extra-intestinal manifestations in immunosuppressed 
patients (Cheifetz, 2011; Herold, 2016). 
Cryptosporidiosis in its most extreme form is generally only found in 
immunocompromised individuals and has therefore until recently been viewed as 
a mainly opportunistic infection and is for example still listed as an AIDS-defining 
illness (Herold, 2016).   
That immunocompetent individuals may also be susceptible to the parasite, even 
if this seems to mostly occur in children, is not wholly new (Casemore et al., 
1985), but nevertheless the impact of this parasite on diarrhoeal disease globally 
had not been realized until recently (Striepen, 2013). 
 
3.3. Current diagnostic methods  
There is a variety of diagnostic tests available for the detection of 
Cryptosporidium spp. in faeces. The gold standard for diagnosis is generally stool 
microscopy using the Ziehl-Neelsen or modified acid-fast staining method. 
Oocysts are then identified under a conventional light microscope (CDC - Global 
Health Division of Parasitic Diseases and Malaria, 2016). This method has proven 
to be very specific but unfortunately necessitates a high level of training and 
experience in differentiating oocysts of Cryptosporidium from debris or other 
parasites, like Cyclospora cayetanensis. In addition, the preparation and 
subsequent microscopy are quite time consuming.   
12 
 
Therefore, methods such as PCR or even simpler RDTs are up and coming as 
with many other microbial pathogens. The main advantage for RDTs is that they 
are easy to use and do not require special training, however, they usually require 
another more sensitive method to confirm any positive or negative finding.  
PCR on the other hand is extremely sensitive but requires expensive equipment 
and professional training. 
 
3.4. The treatment dilemma 
Effective treatment of acute Cryptosporidiosis has long proven to be elusive. Part 
of the problem is the relatively small number of cases and the illness being 
disregarded as an exclusively opportunistic infection with no impact on healthy 
individuals. Difficulties arise through the parasite’s location intracellularly, the 
necessity of targeted treatment so as not to further disrupt the gut’s microbiome 
and the parasite’s possible resistance mechanisms (Mead, 2002).  
Treatment regimens with different types of antibiotics have been used in the past 
with mostly unsatisfying outcomes. At present the only FDA approved drug for 
Cryptosporidiosis is Nitazoxanide, a broad-spectrum anti-infective drug belonging 
to the class of thiazolides (Shakya et al., 2017), which has been shown to aid 
recovery in immunocompetent individuals, but is not recommended for individuals 
<12 months of age, thereby excluding a significant number of patients. 
Unfortunately, it has next to no effect in immunocompromised patients, who are 
of course in much greater need of an effective treatment (Abubakar et al., 2012; 
Amadi et al., 2009).  
Drug development and subsequent approval are a costly and complicated 
process. A study published in 2017 conducted a high-throughput screen for 
possible new drugs against Cryptosporidium spp.. This resulted in the 
identification of several possible drugs,  clofazimine is such a drug thus far used 
in the treatment of leprosy (Love et al., 2017).  
Despite these promising findings an effective, targeted treatment for those most 




3.5. Possible modes of transmission 
Faecal-oral transmission has long been hypothesized as the main mode of 
transmission in individual cases, whereas outbreaks of cryptosporidiosis have 
been traced back to contaminated water sources, especially swimming pools in 
Europe or North America (Efstratiou et al., 2017).  
Seeing as newer studies show more cases outside of these documented 
outbreaks especially in children (Kotloff et al., 2013; Platts-Mills et al., 2015) and 
without the otherwise characteristic outbreak-like case accumulation, it is unclear 
what the main route of infection is. 
Aside from faecal-oral transmission and contaminated water sources as sources 
of infection, recent studies have also given weight to the possibility of airborne 
infection. (Mor et al., 2010; Sponseller et al., 2014) 
Newer insights illustrate that Cryptosporidium spp. are capable of extracellular 
replication (Aldeyarbi & Karanis, 2016) and might be able to survive and replicate 
in biofilms (Ryan et al., 2016). This poses problems for monitoring systems that 
might not register the presence of oocysts in drinking water, because they are 
held up in bacterial biofilms, where they accumulate and are released in bulks, 
additionally monitoring systems tend to focus on the oocyst stages, but seeing as 
replication is ongoing the contamination might be missed entirely or severely 
underestimated (Ryan et al., 2016).  
Contrary to other microbes that can be transmitted through water, chlorination 
has next to no effect on the very hardy Cryptosporidium oocysts. They are poorly 
susceptible to alcohol, chlorine or iodine disinfection (hence the outbreaks in 
public swimming pools) and are only eliminated by reverse osmosis filters or 
boiling water for at least 1 minute (Centers for Disease Control and Prevention et 
al., 2015a). This makes them more difficult to eliminate than most other water 
transmittable pathogens. 
Since studies concerning the parasite’s mode of transmission have been mainly 
conducted in developed countries following outbreaks, there is a certain bias in 
the knowledge regarding transmission accumulated through these investigations. 
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It has been assumed that outbreaks of cryptosporidiosis are simply not identified 
in developing countries due to lack of readily available diagnostic tools (Mmbaga 
& Houpt, 2017) and appropriate monitoring of disease outbreaks in general 
(Efstratiou et al., 2017). This lack of conclusive epidemiological data hampers 
researchers looking for possible modes of transmission.  
A review by Aldeyarbi et al., (2016) cites that many water sources throughout 
Africa are contaminated, but whether it is the consumption of contaminated water, 
human-human or human-animal interaction that then leads to infection cannot be 
readily determined. 
In any case further investigation is necessary, by first establishing the overall 
number of actual cases in developing countries and then delineating possible 






4. Material & Methods 
4.1. Material 
Equipment 
▪ Stool containers 
▪ Gloves 
▪ Cell culture plates 
▪ Eppendorf tubes 
▪ Inoculation loops 
▪ Pipettes 




▪ PCR Machine ROTOR GENE Q 
Rapid Diagnostic Tests 
▪ CerTest Cryptosporidium Kit 
▪ SD Rapid Test Rota/Adenovirus Kit 
Microbiological Culture 
▪ McConkey Agar 
▪ Salmonella-Shigella Agar 
▪ Hektoen Agar 
▪ Müller-Hinton Agar 
▪ Brain-Heart-Infusion 
▪ Antibiotic Diffusion Discs  
▪ Gram-staining equipment 
▪ Oxidase test 
▪ API 20E 
Multiplex-PCR 
▪ MO BIO PowerSoil DNA Isolation kit 
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▪ Qiagen, HotStarTaq Master Mix Kit 
▪ Roche, MgCl2 25mM 
▪ Primers: 
o E.histolytica:  
Ehd‐239F: 5´-ATT GTC GTG GCA TCC TAA CTC A‐3´  
Ehd-88R: 5´-GCG GAC GGC TCA TTA TAA CA-3´  
E.hist T: 5´-Joe-TCA TTG GAA TGA ATT GGC CAT TT-BHQ1-3´ 
o Giardia lamblia:  
Giardia F: 5´-GAC GGC TCA GGA CAA CGG TT-3´  
Giardia R: 5´-TTG CCA GCG GTG TCC G-3´  
Giardia T: 5´-Fam-CCC GCG GCG GTC CCT GCT AG-TAMRA‐3´ 
o Cryptosporidium parvum:  
Crypto F: 5´-CGC TTC TCT AGC CTT TCA TGA-3´  
Crypto R: 5´-CTT CAC GTG TGT TTG CCA AT-3´  
Crypto T: 5´-Rox-CCA ATC ACA GAA TCA TCA GAA TCG ACT 
GGT ATC-BHQ2-3´ 
o Cyclospora cayetanensis:  
Cyclo F: 5´-TAG TAA CCG AAC GGA TCG CAT T‐3´  
Cyclo R: 5´-AAT GCC ACG GTA GGC CAA TA-3´  
Cyclo T: 5-Cy5-CCG GCG ATA GAT CAT TCA AGT TTC TGA CC-
BHQ2-3´ 
o Phocin Herpes Virus 1 (internal Control):  
PhHV F: 5´-GGG CGA ATC ACA GAT TGA ATC-3´  
PhHV R: 5´-GCG GTT CCA AAC GTA CCA A-3´  
PhHV T: 5´-Cy5.5-TTT TTA TGT GTC CGC CAC CAT CTG GAT 
C-BBQ-3´ 
Software 
▪ JMP 13 
▪ Microsoft Office 2016 






4.2.1. Study design 
With the goal of determining possible modes of transmission for Cryptosporidium 
parvum/hominis in Sub-Saharan Africa a multi-centric, non-interventional 
observational study was conducted with CERMEL in Lambaréné as one of the 
four study sites. To investigate the circumstances surrounding a patient’s 
infection with Cryptosporidium spp., children between 0 and 5 years of age, 
presenting at one of the two study hospitals with diarrhoea were included and 
subsequently screened for the parasite. Once a positive index case was identified 
an out-break-like investigation into that patient’s environment was conducted with 
the goal of collecting information about the living circumstances of the patient and 
including family members, friends and animals that the patient was in contact 
with.  
To gain more insight into the general epidemiology of diarrhoeal disease in 
children below 5 at the study site, I devised an additional study protocol, keeping 
within the non-interventional observational study design, with the aim of collecting 
additional clinical data on patients and screening for other pathogens known to 
cause diarrhoea in children. The data analysed in this dissertation was mainly 
generated through this ancillary study with the primary focus being the pathogen 
distribution and clinical characteristics of the patients.  
Data from the household surveys conducted for positive index cases was not 
used in this thesis. 
The ancillary study was approved by the Comité d’Ethique Institutionel 





2 See appendix 
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4.2.2. Study site 
The study sites for the primary recruitment of initial patients were the Albert 
Schweitzer hospital (HAS) and the regional hospital Georges Rawiri (CHRGRL) 
in Lambaréné. These two are the main health care centres in Lambaréné, which 
also provide health care for patients coming from much farther away. For the 
study only patients from Lambaréné and its immediate surroundings were 
considered, which means we included patient’s residing as far as 20km from 
Lambaréné’s centre. Lambaréné, the seventh biggest city in Gabon with a 
population of approximately 21 000 people (Worldometers, 2019), is situated on 
the Ogooué river just south of the equator. The climate is typical for the tropical 
rainforest with high levels of humidity and two types of seasons alternating. Rainy 
season from March to May and October to December, characterized by high 
levels of temperature and humidity, as well as heavy rains and thunderstorms as 
opposed to lower temperatures (20°- 27°C) and the near complete absence of 
rainfall during dry season from January to February and June to September 
(Deutscher Wetterdienst, n.d.). The change of climatic conditions as well as the 
accompanying change in water access, mosquito vitality lead to a certain 
seasonality not only in malaria incidence but also in the incidence of diarrhoeal 






Figure 3: Data collected from the hospital register of the paediatrics’ department at the Albert Schweitzer 
Hospital (HAS) in Lambaréné, Gabon 
 
4.2.3. Recruitment 
The recruitment process started in the respective hospitals’ patient reception 
area. Patients below 5 years of age for whom diarrhoea was cited as the main 
complaint, were selected and the study procedures explained to the parent or 
guardian present. After obtaining written informed consent, two standardized 
questionnaires3 were filled out and a basic clinical examination was conducted, 
assessing the status of hydration using a 4-item, 8-point Clinical Dehydration 
Scale (see Table 1), that groups the patients assessed into three groups. No 
dehydration with a score of 0, mild dehydration (score 1-4) and moderate to 
severe dehydration (score 5-8) (Goldman et al., 2008). Additionally, weight, 
further symptoms and medication intake were recorded. Afterwards a stool 
 
 















collection tube was provided with instructions on sample collection to the parent 
or guardian.  
Table 1: Clinical Dehydration Scale established by Goldman et al., 2008. 
 
Exclusion criteria were children not meeting the criteria defining diarrhoea, which 
in this study were the passage of three or more liquid stools in 24 hours during at 
least one of the last three days, as well as children living outside of the study area 
and children older than five years. 
 
4.2.4. Sample processing and diagnostic methods 
Stool samples from initial patients were collected during the first 48 hours after 
inclusion either at the hospital or at the patient’s home. Samples were 
immediately put on ice and transported to the respective laboratories.   
For the initial patients an RDT for Cryptosporidium was performed in the 
parasitology laboratory. Conventional microbiological culture and an RDT for 
Rota-/Adenovirus were performed in the microbiology lab. Conservation was 
done in Parasitology for PCR at -20°C. If there was a sufficient amount of sample, 
part of it was also conserved at -20°C in the Microbiology lab for possible further 
testing.  





For initial patients a Multiplex PCR detecting Giardia intestinalis and Cyclospora 
cayetanensis in addition to Cryptosporidium spp. was run. 
 
 
Figure 4: Testing algorithm for stool samples collected within 48 hrs of patient’s inclusion into the study. If 
sample amount was sufficient part of the sample was conserved at -20°C. 
 
4.2.4.1. RDTs and Microbiological testing 
The RDT used for the detection of Cryptosporidium oocysts was a coloured 
chromatographic immunoassay using a lateral flow technique. The same 
principle applies to the RDT for Rota-/Adenovirus.  
Testing for bacterial pathogens followed ATCC standards for microbiological 
testing of specimens. All tests are explained in detail in “Introduction to 
Microbiology” (American Type Culture Collection (ATCC), 2015). Culture plates 
containing agar and specific conductive and inhibiting factors for the selective 
growth of the most common bacterial agents (e.g. Shigella spp., Salmonella spp., 
E. coli) were used, MacConkey agar, Hektoen enteric agar and Salmonella-
Shigella (SS) agar respectively. After incubation at 37° C for 16 – 24 hours, 












morphology examination, Gram-staining and Oxidase testing. Depending on the 
outcome of this characterization, further tests cataloguing biochemical reactions 
using different API kits were performed. In case a pathogen was identified, anti-
microbial-susceptibility testing using Müller-Hinton Agar was added.  
If no suspicious growth was observed after a further incubation period of up to 48 
hours on the initial agar plates, the sample was declared negative for the bacterial 
pathogens sought for. 
 
 
Figure 5: Simplified algorithm for microbiological testing on stool samples. 
 
4.2.4.2. Multiplex-PCR 
To confirm the results of the Cryptosporidium RDT and to identify other 
pathogenic parasites, a Multiplex-Realtime-Quantitative-PCR using the Qiagen 
Rotor Gene Q PCR instrument was performed on most samples.  
The DNA needed for the following amplification was extracted from the samples 
using MO BIO PowerSoil DNA Isolation kit according to the protocol established 









manual4. It is especially designed to remove all manner of PCR amplification 
inhibitors from a variety of sample types. The procedure comprises several steps 
using chemical and mechanical methods to achieve cell lysis and ends with the 
DNA being captured on a silica membrane and then washed off. 
After obtaining a sufficient amount of DNA from each sample PCR was performed 
according to the procedure described in the SOP, which had also been 
established for the CRYPTO multi-centre study. 
Each sample was added to a so called “reaction mix” containing HotStarTaq 
Master Mix, magnesium chloride, Primer Mixes for Cryptosporidium parvum, 
Cyclospora cayetanensis, Giardia lamblia and PhHV and PhHV plasmide. 
PhHV plasmide was used as an inhibition control. Since the plasmide and 
respective primers are added to every test tube, all samples should show an 
amplification of PhHV plasmide, unless some type of amplification inhibition is 
present (e.g. bile salts or complex polysaccharides (Bessetti, 2007)). 
Mixes for each sample were pipetted into Rotorgene tubes, as well as positive 
controls containing specified amounts of parasite DNA for each specimen and a 
negative control containing only the reaction mix and nuclease-free water. The 
tubes were loaded into the RotorGeneQ machine and a standardized programme 
started.  
This programme begins with a 15 minutes activation phase at 95°C. The HotStar 
Taq-Polymerase5 used is inactive at room temperature, making it possible to set 
 
 
4Available at : https://www.qiagen.com/de/resources/resourcedetail?id=5c00f8e4-c9f5-4544-
94fa-653a5b2a6373&lang=en (20th January 2020) 
 
5 Taq-Polymerase is derived from a very heat-stable bacterium, Thermus aquaticus, that can 
withstand very high temperatures and shows a maximum activity at 75° to 80°C and 2-4 mM 
MgCl2 concentration. (Lawyer et al., 1993) Optimum temperature for DNA-polymerases shows 
great variation depending on the organism’s normal environment. For the E. coli DNA-polymerase 
a temperature of 37° C is optimal, since this bacterium colonizes and therefore replicates in open 
nature or in different eukaryotic species. This enzyme would denaturate alongside the DNA during 
the first part of PCR and would therefore have to be newly added after denaturation in each cycle. 
24 
 
the reaction mix up at ambient temperature, but necessitating this so-called 
activation period to ensure optimal enzyme function further on.  
The actual PCR then commences with an initial denaturation of the double-
stranded DNA at 95° C for 15 seconds, then continuing with 30 seconds of 
annealing or renaturation where primers bind to their respective target sites in 
the sample DNA. This leads to the polymerase binding to the 3’-hydroxyl end of 
the primers once the synthesis phase at 72° C for another 30 seconds starts. 
The polymerase then joins complementary bases to the existing DNA strand, 
resulting in a newly synthesized strand of double-stranded DNA. The synthesis 
is stopped by the temperature being raised to 95° C, resulting in the separation 
of polymerase and DNA and further denaturation of the newly synthesized 
strands of DNA. This leads to another round of amplification, repeating the three 
phases of denaturation, annealing and synthesis until after 45 cycles the 
amplification is complete and the mix is cooled down to 40° C for 30 seconds and 
can be analysed. 
The mix contains specific fluorescent reporter probes, that can only bind to a 
specific region in the targeted DNA. These probes are marked with a fluorescent 
reporter and a quencher, that prevents fluorescence. Once the target DNA is 
denatured, the probes hybridize with the DNA. Fluorescence is however still 
quenched. Only once the Taq-Polymerase has connected the probe with the 
newly synthesized DNA strand, is the reporter released and can then emit 
fluorescence. The more strands are amplified, the more fluorescence is emitted, 
thus making it possible to measure the amount after each round of amplification. 
This creates a characteristic curve only when amplification occurred. Since a so 
called Realtime-PCR was conducted, amplification was measured after each 
cycle, showing how the amount of DNA contained in the mix grows exponentially. 
When comparing this to the curve measured in the positive controls, that 
contained a known quantity of DNA it becomes possible to quantify the amount 
contained in the original sample. This is not possible when using other PCR 
methods, that often use gel-electrophoresis to determine whether the sample 





Figure 6: PCR result from a run containing two positive patients' samples. Each patient's samples were 
included twice in the run. 
 
4.2.4.3. Additional diagnoses 
Systemic infections, like malaria and measles, that can present diarrhoea as one 
of their symptoms, diarrhoea sometimes even predating other more characteristic 
symptoms, were also taken into consideration. Diagnosis was made by hospital 
staff in these cases and information either noted down directly or collected from 
patient’s files. 
Furthermore, the wet-mound technique, a standard diagnostic test performed in 
the microbiology laboratory, was performed on samples (American Type Culture 
Collection (ATCC), 2015). This method is conducted by suspending a small 
amount of the fresh sample in saline solution and examining a drop under a 
conventional (light-)microscope. This technique can be used to identify different 
parasites, as well as fungi or bacteria. Certain parasites, that can be thus 
identified, such as helminths are not generally considered to be causes of 
diarrhoea but can be associated with contaminated food or water and the 





4.2.4.4. Statistical analysis 
Statistical analysis was performed mainly using JMP Software (Version 13) and 
Excel (Microsoft Office 2016) for Figure 3 and Figure 9. Likelihood-ratio Χ2-test 
was used to test for associations between pathogens and clinical findings or 
seasons, as well as Odd’s Ratio to measure association between pathogens and 
age groups, as well as pathogens and symptoms, when likelihood-ratio Χ2-test 
had shown a significant association. To counteract the problem of multiple 







5.1. Study cohort 
From the 20th February 2017 until the 17th November 2017 100 initial patients 
were recruited and a stool sample analysed. 57% were recruited at the Albert 
Schweitzer Hospital (HAS) with 33% admitted at the regional Hospital Georges 
Rawiri (CHRGRL) and 10% for which the hospital of admission had not been 
recorded. Distribution across seasons, namely rainy and dry, was quite equal, 
with slightly more patients recruited during rainy season (56%).  
49% of the initial patients were female, 51% were male. The mean age on 
admission was 14.2 months with a majority of 67% of children being between 6 
and 24 months old. 
Weight for age percentiles recorded were mostly below 50% (65% of patients) 
with 48% of patients coming in at less than 20%.  
Most patients were reported to have been breast-fed (86%). Of those 6 months 
old or younger 47.6% were still being exclusively breast-fed and of those older 
than 6 months 38% had been breast-fed between 6 to 12 months. The mean 
duration of breast-feeding was 7.8 months. 






Table 2: Demographic data of study cohort. Information on the duration of breast-feeding was not clear in 
some cases and the weight of 7 of the patients, as well as the hospital at which 10 of the patients first 
presented was not recorded correctly and is therefore marked as unknown. 
Sex N %  
F 49 49% 
M 51 51% 
All 100  
Age categories     
0 – 6 months 21 21% 
6-24 months 67 67% 
Older than 24 months 12 12% 
All 100  
Breastfed 0-6 months of age     
Exclusively 10 48% 
Already weaned 5 24% 
Never 5 24% 
Unknown 1 5% 
All 21  
Breast-fed older than 6 months     
Up to 6 months of age 24 30% 
Up to 12 months of age 30 38% 
More than 12 months 10 13% 
Never 8 10% 
Unknown duration  1 1% 
Unknown  6 8% 
All 79  
Weight for Age-Percentile     
Above 50% 28 28% 
Between 20% and 50% 17 17% 
Below 20% 48 48% 
Weight unknown 7 7% 
All 100  
Season     
Dry Season 44 44% 
Rainy Season 56 56% 
All 100  
Hospital     
CHRGRL (Regional Hospital) 33 33% 
HAS (Albert Schweitzer Hospital) 57 57% 
Unknown 10 10% 








Of the 100 initial patients 81 were hospitalised. Upon inclusion into the study, 
basic clinical characteristics were recorded (Table 3).  
The median time between the onset of diarrhoea until seeking health care at one 
of the study hospitals was 4 days with some patients having waited up to a month 
until presenting at a hospital. 
Upon admission 88% of patients showed signs of dehydration, with 26% being 
classified as moderately to severely dehydrated. 
For 23% of patients the parent or guardian reported blood in the stool, and 64% 
had mucus in their faeces. 
The most common associated symptoms were stomach pain, vomiting, loss of 
appetite, fatigue and fever. Additionally, 38% of patients were reported to have a 
cough as well.  
In 23% of cases the parent or guardian reported that, aside from the initial patient, 
at least one other member of the child’s household was or had very recently 
suffered from diarrhoea.  
Table 3: Clinical presentation of patients 0-5 presenting at OPD with diarrhoea. Assessment of clinical 
symptoms was not complete for all patients. Percentages are based on results of patients assessed for the 
specific characteristic. 
 N %  Median Min Max 
Out-patient 19 19.0% . . . 
In-patient 81 81.0% . . . 
Total 100 100.0% . . . 
       
Time since onset of diarrhoea (days) 98 . 4.0 1 30 
Stools per day 98 . 4.0 1 9 
Temperature in °C  93 . 38.7 35.8 40 
          
Signs of dehydration (CDHS) 91     
No dehydration (0) 11 12.1% . . . 
Some dehydration (1-4) 56 61.5% . . . 
Moderate to severe dehydration (5-8) 24 26.4% . . . 
All 91  . . . 
Stool characteristics           
Blood  23 23.2% . . . 
Mucus 63 63.6% . . . 
Blood and Mucus 15 15.2% . . . 
All 99          
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 N %  Median Min Max 
 
Reported symptoms 
     
Stomach pain 49 67.1% . . . 
All 73  . . . 
Vomiting 49 52.1% . . . 
All 94  . . . 
Loss of appetite 65 65.0% . . . 
All 100  . . . 
Fatigue 72 73.5% . . . 
All 98  . . . 
Fever 51 60.7% . . . 
All 84  . . . 
Cough 32 38.1% . . . 
All 84  . . . 
Other symptoms 25 29.8% . . . 
All 84  . . . 
Chronic disease reported 6 6.5% . . . 
All 93  . . . 
Members of the same household afflicted            95          
None  73 76.8% . . . 
1 or more household members 22 23.2% . . . 
 
For 3 of the patients with a positive RDT for Cryptosporidium spp. an HIV test 
was performed, the other Crypto positive patients were not tested due to the 
respective parents’ objection. All three patients tested were negative. 
Antibiotic treatment 
Most patients had already received some form of treatment when presenting at 
the hospitals’ OPDs. ORS, antibiotics and various other medication, including 
anti-motility drugs, were employed.  
Table 4 gives an overview of the number of patients that received any of the listed 
treatment options during the course of their illness.  
Table 4: Treatments administered either before or during hospitalization to patients 0-5 years that presented 
at OPD with diarrhoea. (Total: 100) 





Number of patients 67 15 26 58 1 
 
23 patients (53% out of 43 patients for whom type of antibiotic administered had 
been noted) had been treated with metronidazole (in various combinations with 




affect bacteria commonly causing diarrhoea and would in this context mainly be 
used to eradicate Giardia int. or Entamoeba hist. (Herold, 2016). Regarding 
infection or carriage of Giardia int., no difference could be observed between 
patients who had been treated with metronidazole prior to presentation at OPD 
or those that had not. 
Regarding the prescription of antibiotics at the study sites, patients were more 
likely to receive antibiotic treatment when presenting bloody stool, as required by 
the WHO guidelines. Nevertheless, most patients, that were treated with 
antibiotics, had not reported bloody stools. 
 
 
Figure 7: Administration of antibiotics to patients 0-5 years with diarrhoea before and after admission in the 
OPD broken down by whether bloody stools had been reported or not. 
 
 
5.2. Pathogens identified 
While each sample was tested for Cryptosporidium spp. by RDT, not all of the 
remaining tests could be performed. This was mainly due to an insufficient 
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amount of the samples provided. The following table presents an overview of the 
tests conducted (Table 5).  
Table 5: Number of samples for which the different tests were conducted. Tests missing were not performed 









  N % N % N % N % 
missing 0 0% 6 6% 16 16% 13 13% 
performed 100 100% 94 94% 84 84% 87 87% 
 
Of the 100 samples collected in total, all tests were conducted for only 76 
samples. Of the 24 samples, that had not been fully analysed as required by the 
study protocol, 15 were positive for one or more pathogens and three were 
clinically diagnosed with measles, which in this study was also viewed as a cause 
of diarrhoea.  
The remaining 6 patients, whose samples had not been fully analysed and for 
whom no cause had been identified, were excluded from the further analysis in 
this thesis, leaving 94 patients to be analysed in total. The 18 with one or two 
tests missing were included in so far as the pathogenic agent identified is further 
analysed but were excluded when specifically analysing the impact of co-infection 
with multiple pathogens. 
In total, an infectious agent was detected for 61 (65%) of the initial patients. 
The most frequently isolated pathogen was Giardia int. (20%), directly followed 
by Cryptosporidium spp. in 19% of cases. The third most frequently isolated 
pathogen was rotavirus with a total of 14 cases (15%). 
Other pathogens isolated were Shigella spp. (5%), E. coli (2%), Cyclospora 
cayetanensis (3%) and one case of adenovirus (1%). Additionally, Taenia spp. 
was identified in 2 samples (2%) and eggs of Ascaris lumbricoides were present 
in one sample (1%).  
In 42 of the samples (45%), no pathogen could be identified by the tests 




either malaria or measles at the respective hospitals, which in these cases was 
assumed to be the cause of diarrhoea. Thus leaving 33 of the participants (35%) 
for whose symptoms no etiologic agent could be determined. 
 
 
Figure 8: Infectious agents and diseases identified in children 0-5 years presenting at the hospital with 
diarrhoea. 
 
Co-infections with multiple pathogens were very common as illustrated in Figure 
9. 16% of patients were positive for more than one pathogen with 
Crypotsporidium spp. and Giardia int. most frequently encountered in the same 
sample (5% of all samples). 
In fact, patients infected with Cryptosporidium spp.  or Giardia int.  were more 
likely to be diagnosed with an additional infectious agent present in the same 
sample than without (Χ2=9.2; p<0.01 and Χ2=23.1; p<0.0001, respectively).  
Rotavirus showed no association with co-infection (X2=2.9; p=0.09). 
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When utilising the Bonferroni correction however, only Giardia int.’s association 
with co-infection remains significant (p<0.004). 
Odds of these pathogens being isolated with at least one other infectious agent 
present are displayed in Table 6. 
Table 6: Odds of Cryptosporidium spp. and Giardia int. to be present in a case of co-infection. Only the 
association of Giardia int. is statistically significant when utilising Bonferroni correction for multiple 
comparisons. 
 Co-infection + Co-infection - Odds Ratio Lower 95% Upper 95% 
Cryptosporidium spp. 7/15 7/66 7.4 2 26.6 
Giardia int. 10/15 5/66 24.4 6 99.8 
 
Pathogens like Cyclospora cayetanensis and Taenia spp. were never isolated 
without another pathogen present. 
 
 
Figure 9: Distribution of mono- and coinfections with the respective infectious agents and diseases identified 





























































5.3. Explorative analyses 
While the small sample size of my pilot study limits the statistical power of further 
analyses as to correlations in disease manifestations and pathogens, I performed 
exploratory analyses regarding the spectrum of pathogens identified in different 
age groups or in patients exhibiting different symptoms. 
Age distribution 
As illustrated in Table 7, the distribution of identified pathogens differed between 
age groups. Due to the three age groups not being of similar size, most of these 
observations are not statistically significant. Nevertheless, for Cryptosporidium 
spp. the odds of a patient being infected were 6.1 in children aged 6 to 24 months 
as compared to infants (0- 6 months). (CI: [1.1, 114.6]; p=0.04), likely reflecting 
different levels of exposure (breast feeding versus solid foods). 
 
Table 7: Pathogen distribution by age groups 
  Pathogens N % of Total 
0-6 months (n=19) Cryptosporidium spp. 1 1% 
 Giardia intestinalis 3 3% 
 Rotavirus 5 5% 
 Adenovirus 0 0% 
 E. coli 0 0% 
 Shigella spp. 0 0% 
 Plesiomonas shigelloides 0 0% 
 Cyclospora cayetanensis 0 0% 
 Taenia spp. 0 0% 
 Ascaris lumbricoides 0 0% 
 Malaria 0 0% 
 Measles 1 1% 
 No infectious agent identified 10 11% 
6-24 months (n=63) Cryptosporidium spp. 16 17% 
 Giardia intestinalis 11 12% 
 Rotavirus 9 10% 
 Adenovirus 1 1% 
 E. coli 1 1% 
 Shigella spp. 4 4% 
 Plesiomonas shigelloides 1 1% 
 Cyclospora cayetanensis 2 2% 
 Taenia spp. 1 1% 
 Ascaris lumbricoides 1 1% 
 Malaria 5 6% 
 Measles 3 3% 
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  Pathogens N % of Total 
 No infectious agent identified 20 21% 
>24 months (n=12) Cryptosporidium spp. 1 1% 
 Giardia intestinalis 5 5% 
 Rotavirus 0 0% 
 Adenovirus 0 0% 
 E. coli 1 1% 
 Shigella spp. 1 1% 
 Plesiomonas shigelloides 0 0% 
 Cyclospora cayetanensis 1 1% 
 Taenia spp. 1 1% 
 Ascaris lumbricoides 0 0% 
 Malaria 2 2% 
 Measles 1 1% 
 No infectious agent identified 3 3% 
 
For Giardia int. and rotavirus no statistically significant odds could be determined 
but nevertheless a certain trend as illustrated in Figure 10 can be distinguished.  
For infection with Giardia int. odds were highest for group 3 (older than 24 
months) with 3.8 (CI: [0.7, 23.2]; p>0.05) compared to group 1 (0-6 months) and 
3.4 (CI: [0.9, 12.7]; p>0.05) compared to group 2 (6 to 24 months).  
For rotavirus the odds of infection in the first age group (0-6 months) were 2.1 
(CI: [0.6, 7.3]; p>0.05) as compared to the second age group (6 to 24 months).  
The odds of no infectious agent being identified were higher in the first age group 
(0-6 months) compared to the second (6 to 24 months) and third (>24 months) 






Figure 10: Distribution of pathogens in the different age groups of children between 0-5 years presenting at 
the hospital with diarrhoea.  
 
Malnutrition 
No significant difference in the spectrum of infectious agents could be observed 
between chronically malnourished patients and those with a healthy weight-for-
age ratio. Children had been grouped into three groups by the weight-for-age 
percentiles determined (above 50%, between 50 and 20%, below 20%), but no 
significant correlations of infectious agents identified could be determined 
(X2=4.6; p=0.2). 
Symptoms 
As illustrated in Figure 11 the various symptoms exhibited by patients in addition 
to diarrhoea varied depending on which pathogens were identified. Symptoms 
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mainly recorded were those generally associated with gastro-intestinal infections 
like stomach pain, vomiting, loss of appetite, fatigue and fever, however since a 
substantial number of patients (38%) had also been reported to experience an 
involvement of the respiratory tract (coughing) (Table 3) and infections with 
rotavirus are reported to involve the respiratory tract in up to 50% of cases, as 
well as the possibility of patients developing a form of respiratory 
cryptosporidiosis (Mor et al., 2010; Sponseller et al., 2014), I decided to include 
coughing as a symptom in this analysis.  
Nearly all symptoms could be found with each of the respective pathogens, 
excepting Shigella spp. (which was not found in patients with cough). All patients 
diagnosed with measles had run a fever (X2=5; p=0.03), which was expected 
since this symptom is one of the diagnostic criteria (Herold, 2016), and an 
infection with rotavirus was positively associated with vomiting (X2=10.6; 
p=0.001).  
Infection with Giardia int. was negatively associated with vomiting (X2=3.9; 
p=0.049) and positively associated with coughing (X2=5; p=0.02).   
When using the Bonferroni correction, the required p-level for statistical 
significance changes to p<0.004, leaving only the positive association of rotavirus 
with vomiting as statistically significant.   
 
Table 8: Odds of patients infected with rotavirus or Giardia int. reporting vomiting. 
 Vomiting + Vomiting - Odds Ratio Lower 95% Upper 95% 
Rotavirus 12/48 1/41 13.3 1.7 107.7 
Giardia int. 6/48 12/41 0.3 0.1 1 
 
Table 9: Odds of patients infected with Giardia int. reporting coughing. 
 Cough + Cough - Odds Ratio Lower 95% Upper 95% 
Giardia int. 9/30 5/50 3.9 1.1 12.9 
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Figure 11: Distribution of symptoms exhibited by infections identified in children 0-5 years presenting at the hospital with diarrhoea. Pathogens that had been found in less 
than 5 cases were excluded from analysis. 
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When excluding cases of co-infection, the association previously shown for 
infection with rotavirus remains the same (X2=10.6; p=0.001), additionally an 
association with fatigue can be shown (X2=5.1; p=0.02; p<0.005 required after 
Bonferroni correction).  
Odds ratios could not be calculated due to all nine cases of infection with rotavirus 
presenting with the respective symptom, leading to a cell count of zero for those 
not infected. 
Since less than 5 cases of mono-infection with Shigella spp. and malaria had 
been recorded, these infections were not further analysed. Moreover 3 out of the 
5 cases diagnosed with measles had not been fully analysed as required by the 
study protocol, therefore measles was also excluded from the further analysis in 
this case.  
While not statistically significant in this population, a higher percentage of patients 
were reported to experience stomach pain and vomiting when only Giardia int. 
(80%) was present than in all cases of infection with this pathogen (63% and 33% 
respectively). The same can be observed for vomiting in cases of mono-infection 
with Cryptosporidium spp. (83%) and in combined analysis of co- and mono-
infection (53%). 
In reverse, mono-infection with Giardia int. showed a lesser percentage of 






Figure 12: Symptoms by infections with a single pathogen identified and infections with multiple pathogens in children 0-5 years presenting at the hospital with diarrhoea. 
Only pathogens that had been identified in at least 5 cases were included. Cases where not all tests were performed were excluded from the analysis of specific pathogens. 
Those where more than one pathogen had been identified were however included in the group with co-infections. 
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Regarding the excretion of blood or mucus with the patients’ stool, no clear 
association could be found with any specific pathogen. Infection with 
Cryptosporidium or rotavirus showed a negative correlation with the excretion of 
bloody stools (Χ2=5.1; p=0.02 and Χ2=8.3; p<0.01 respectively). Additionally, 
bloody stools were less likely to be found in cases of co-infection (X2=9; p<0.01). 
Bloody stools were more likely to be reported when no infectious agent could be 
identified (Χ2=10.5; p=0.001). After correcting with the Bonferroni correction, this 
leaves co-infection negatively and cases with no infectious agent identified 
associated with bloody stools. (Required p after correction p<0.004) 
Disease severity 
Patients were examined for signs of dehydration on admission to the study. This 
led to a classification of the severity of dehydration into the categories no 
dehydration, some dehydration, moderate to severe dehydration. No significant 
correlation between pathogens and severity of dehydration could be observed. 
 
 
Figure 13: Severity of dehydration recorded in patients 0-5 years presenting at the hospital with diarrhoea 





Disease variability due to seasonal differences is often reported. Overall 56 % of 
patients were included during rainy season as opposed to 44 % during dry season 
(representing 66% and 33% of the study period, respectively).  
In this study the only seasonal difference could be noted for Giardia int. mono-
infection which was more likely during the dry season (X2=10.9; p=0.001). When 
including patients with an additional pathogen, the results are similar with X2=7.1 
and p<0.01, although not statistically significant due to Bonferroni correction 
(p<0.0038).  
While the cases of malaria, which is generally agreed to be linked to mosquitoes 
thriving in rainy season, included in this study do not show a statistically 
significant difference between seasons, the fact that the majority of cases 
recorded in study patients (86%), were recorded during rainy season, can be 
seen as a positive validation of the study results. 
 





5.4. RDT Validation 
Initially, 23 patients had a positive RDT for Cryptosporidium spp.. Of these only 
16 turned out positive on PCR. Additionally, 2 patients with a negative RDT were 
later found to be positive on PCR. Only the cases with a positive PCR were 
considered positive in my analyses. Which leaves a total of 18 cases of infection 
with Cryptosporidium spp. detected in this study. 
This discrepancy between the RDT and PCR results led me to evaluate the RDT’s 
accuracy in the detection of Cryptosporidium spp. oocysts as compared to PCR.  
This leads to a sensitivity of 88.9% (CI: [0.7; 1]), a positive predictive value of 
69.6% (CI: [0.5; 0.9]) and a specificity of 90.8% (CI: [0.8; 0.97]), with a negative 
predictive value of 97.2% (CI: [0.9; 1]). 
Table 10: Comparison of RDT and PCR results. For 6 samples PCR could not be conducted due to 
insufficient quantity of the sample provided. 
  Crypto PCR  
  Positive        Negative      All 
Crypto RDT  N %  N %  N %  
Positive 16 17% 7 7% 23 25% 
Negative 2 2% 69 73% 71 76% 
All 18 19% 76 81% 94 100% 
 
The data analysed here is part of the data used by Manouana et al., (2020) to 





6.1. Study findings  
Pathogen spectrum 
This study confirms some of the conclusions drawn from recent multi-centric 
studies (Kotloff et al., 2013; Platts-Mills et al., 2015) highlighting that the spectrum 
of pathogens responsible for infantile diarrhoea is much more diverse than what 
had been assumed during the last few decades. The 18 cases of infection with 
Cryptosporidium spp. are the first recorded in Lambaréné, Gabon. The numbers 
are consistent with the estimate by Checkley et al. (2015) that around 15 - 25% 
of children with diarrhoea are infected by Cryptosporidium spp., but are not 
officially diagnosed because no adequate testing is performed. This may serve 
to raise local physicians’ awareness of this very important pathogen and in 
general to broaden the range of pathogens taken into consideration when 
deciding the further course of treatment and diagnostics applied.  
Plesiomonas shigelloides was initially not included in the spectrum of pathogens 
sought in our study and the identification of this bacterium in one sample was 
therefore unexpected. There have however been several reports in the last years 
linking it to diarrhoeal outbreaks in Southeast Asia and Africa (Janda et al., 2016). 
Our finding may serve to further confirm this pathogen’s role in diarrhoeal 
disease. 
The high rate of co-infections, 16% in this study as seen in Figure 9, is consistent 
with other studies’ findings (Kotloff et al., 2013; Stockmann et al., 2017; Zhang et 
al., 2016). How this affects the patients compared to mono-infection cannot be 
evaluated due to the small numbers in this study, nevertheless, it can be seen as 
a further incentive to focus more on the actual patho-mechanisms and possible 
pathogen interaction, which may lead to different disease outcomes.  
The role of Giardia int. in diarrhoeal disease is not altogether clear. Giardia int. is 
often associated with traveller’s diarrhoea (Valls et al., 2014), but some studies 
even suggest that it may be protective against diarrhoeal disease (Breurec et al., 
2016; Kotloff et al., 2013; Nhampossa et al., 2015). Our study showed a high 
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prevalence, but since Giardia int. is not viewed as an obligatory pathogen, it 
cannot be determined whether it was a causative agent of diarrhoea or not.  
Other pathogens such as Taenia spp. and Ascaris lumbricoides are not clearly 
associated with diarrhoea, infection does however usually occur through 
contaminated food. The less than ideal hygiene practices leading to this infection 
may have also caused infection with or heightened susceptibility to another 
pathogenic agent that then ultimately caused diarrhoea. In the two cases where 
Taenia spp. were present, this would be Cryptosporidium spp. and Shigella spp..  
Treatment observations 
The observation that many of the children were treated with antibiotics prior to 
hospitalisation and that many then received antibiotic treatment from the doctors 
at the study sites regardless of reporting blood in their stool, is worrisome. 
As outlined in the WHO guidelines on treatment of acute diarrhoea (World Health 
Organization (WHO), 2013b), antibiotics should only be administered in cases 
where there is a high likelihood of infection with Shigella spp., cholera or a severe 
systemic infection, and not generally to avoid destroying even more of the 
patient’s healthy microbiome, which should eventually help the gut recover from 
the infection.  
Furthermore, the very generous administration of metronidazole is problematic 
seeing as it is ineffective against Shigella spp. (World Health Organization 
(WHO), 2005) and would normally only be administered to clear an infection with 
Giardia int.. However, those patients treated with metronidazole were not found 
to be diagnosed more or less often with Giardia int.. Whether this is simply due 
to the parasite having been already cleared or the drug being administered when 
no infection had taken place or improper administration cannot be concluded in 
this setup. 
Explorative analyses 
The varying distribution of pathogens depending on the age of the patients has 
also been observed in other studies (Gasparinho et al., 2016). As demonstrated 




between 6 and 24 months. This ties in with findings from another study conducted 
in Libreville where the prevalence of infection with Cryptospordium spp. was 
highest between 6 and 18 months (Duong et al., 1995, 1991). Rotavirus was more 
prevalent in children below 6 months and Giardia int. was mainly found in children 
older than 2 years. Since Giardia int. is not viewed as an obligatory pathogen, the 
higher prevalence in older children may be due to longer exposure to 
contaminated water and subsequent asymptomatic carriage.  
The reason why some pathogens are more prevalent in certain age groups 
cannot be determined. It may be due to the youngest children still receiving a 
much narrower diet or not being able to move at their own volition thus limiting 
their exposure to certain things or people, that may be the source of infection. 
The fact that rates of infection drop again once children reach 2 years of age 
suggests a certain level of immunity is established to enteric pathogens in general 
throughout the first few years of life.  
Direct correlations between pathogens and disease severity (measured here 
through the CDHS) could not be shown. Rotavirus was positively associated with 
vomiting, but apart from the clear association of measles with fever, which can 
be viewed as a positive control seeing as fever is one of the illness defining 
symptoms (Herold, 2016), no other statistically significant associations could be 
shown (Figure 11 and Figure 12).  
Cryptosporidium spp. and rotavirus were negatively associated with the 
presentation of bloody stools. Since the total number of the other pathogens was 
too small, it was not possible to find any statistically significant association 
between them and certain symptoms.  It would have for example been probable 
to expect a positive association between shigellosis and bloody stools (Herold, 







6.2. Further studies in Gabon and Central Africa 
In the early 1990s two studies were already conducted in Gabon on the 
epidemiology of Cryptosporidium spp.. The studies found a rate of 3.1% in 
children presenting at the hospital for various reasons, not limited to diarrhoea, 
and 24% in children aged between 0 to 2 years whose main complaint was 
diarrhoea (Duong et al., 1995, 1991).  Patients’ immune status was only in so far 
evaluated as malnutrition was recorded, which was in this study correlated with 
higher rates of infestation with Cryptosporidium spp.. This finding could not be 
replicated with the data at hand, possibly due to the smaller sample size 
evaluated. 
The studies by Duong et al. were conducted mainly in Libreville, making this study 
the first survey in Lambaréné, which presents climatic and socio-demographic 
differences. Surprisingly, at the time there was no direct follow-up of this study, 
considering that cryptosporidiosis was still considered a mainly opportunistic 
infection. This may be partly due to the difficulty of accurately diagnosing an 
infection with Cryptosporidium spp.. The advancement in diagnostic methods 
leading to the creation of simple to use RDTs, like the one employed in this study, 
have most certainly led to a higher feasibility of conducting studies on this 
parasite. 
Other studies conducted in Gabon focused either on bacterial or viral causes of 
diarrhoea (Koko et al., 2013; Lekana-Douki et al., 2015).  
As far as the general aetiology of infantile diarrhoea is concerned, there is only 
one study using a case-control approach from the Central African Republic 
available (Breurec et al., 2016). In this study rotavirus was identified as the main 
pathological agent, followed by Shigella spp.. Third place was shared by 
Cryptosporidium spp., astro- and norovirus.  
This scarcity of comparable regional data further highlights the need for a 
concerted effort to better survey the aetiology of childhood diarrhoea in this 
region, for without a better knowledge of the causes any effort to better prevent 




6.3. Study limitations  
Now as for limitations of this study, there is of course the relatively small sample 
size and descriptive nature to consider, making it difficult to draw many 
statistically significant conclusions on the epidemiology of infantile diarrhoea and 
any treatment given to the subjects at the OPD. Furthermore, the study did not 
include any kind of follow up, which prevents me from ascertaining any long-term 
effects or mortality rates and also means that any symptoms occurring later on 
were not taken into account. 
Additionally, due to the study lacking a healthy control group it can only be 
surmised that pathogens identified in the participants’ faeces were the causative 
agents of the symptoms they presented on admission. This assumption is based 
on the viruses, bacteria and protozoa in question having been shown to be 
enteropathogenic in other studies. However, newer studies in this field have 
shown that the simple presence of a pathogen does not necessarily lead to 
disease (Sultana et al., 2017). The mechanisms involved are far more complex. 
It is possible that the patients in this study, especially those infected with 
Cryptosporidium spp., had an underlying cause of immunosuppression, e.g. 
malaria (possibly asymptomatic), HIV or any hereditary cause of immune-
deficiency, that made them prone to infection with any of the infectious agents 
identified, which makes these so called “by-stander” infections and not the direct 
cause of illness.  
Many recent case-control studies found a high number of pathogenic agents in 
the healthy control group, albeit often in lesser quantity than in the symptomatic 
participants (Breurec et al., 2016; Platts-Mills et al., 2014). These findings 
contradict “Koch’s postulates” on causality, which require a pathogen to cause 
disease when introduced into a healthy organism (Sultana et al., 2017). These 
postulates however contain several deficiencies. For example, they discount 
asymptomatic infection, which has been shown in a number of infectious 
diseases, e.g. HIV and tuberculosis (Inglis, 2007). Newer approaches, e.g. the 
Bradford Hill criteria (Hill, 1965), have been established that consider the more 
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complex mechanisms involved, but nevertheless the role of certain infectious 
agents, particularly Giardia int., in diarrhoea has not been clearly defined. 
Pathogen interaction 
A study conducted in China found no positive association of bacterial pathogens, 
except for Shigella spp., with diarrhoea, while remarking that co-infection of 
certain bacteria and rota- or norovirus always led to symptomatic illness (Li et al., 
2016). It has been suggested that an interaction of viruses and bacteria is needed 
to make the gut susceptible to infection, this does however require further studies 
for confirmation (Miura et al., 2013). The common occurrence of more than one 
parasite Figure 9 may also indicate a certain level of interaction between the 
respective pathogens, however, research in this field remains scarce.  
Considering the complex interactions of the gut’s microbiome, host immune 
system and these entero-pathogens, the pathogens isolated in this study can only 
be seen as possible causes of the symptoms presented. 
Diagnostic methods 
Another limitation involves the diagnostic methods used. While bacterial culture 
is a very sensitive diagnostic method and RDTs do produce relatively reliable 
results, molecular diagnostic methods such as PCR may lead to even more 
accurate diagnoses, as has been demonstrated in other studies (J. Liu et al., 
2016). As can be seen in our comparison of the RDT and PCR for 
Cryptosporidium spp. (Table 10), PCR is still the more specific method and 
relying only on RDTs will not achieve the same measure of reliability in the data 
collected.  
Following the old adage “seek and ye shall find”, it is probable that a reanalysis 
of all of the patients’ samples using molecular techniques would lead to even 
higher rates of pathogens identified, as has been demonstrated by J. Liu et al., 
(2016) in a re-evaluation of the GEMS multi-centre study. Especially for the 
bacterial pathogens, a PCR might show a completely different number of positive 




stool sample may have also hampered the accurate diagnosis in several cases, 
by preventing bacterial growth in the laboratory.  
The addition of further pathogens to the analysis could also lead to a more 
differentiated picture. For example, adding sapovirus, astrovirus and norovirus, 
as well as Campylobacter jej., would be reasonable when considering other 
studies’ findings (Kotloff et al., 2013; Lekana-Douki et al., 2015; J. Liu et al., 
2016). 
Socio-demographic determinants 
A possible cause of bias in this study is that only children presenting at one of the 
study hospitals were considered for inclusion. While difficult to organize 
differently, a broader community screening could have been helpful to augment 
the number of inclusions and prevented the possible bias of the study towards 
children from somewhat wealthier families and more severe cases of diarrhoea. 
As in many countries not only in the developing world, a child suffering from 
diarrhoea would not necessarily be brought to the next healthcare facility. While 
having long been shown to be associated with any number of negative effects on 
child development and not seldomly proving to be fatal to young children, 
diarrhoea is still very often seen as an illness that can be very well managed 
without the assistance of medical personnel and children affected would therefore 
not be seen at a hospital, especially if the family is financially weak to begin with. 
 
6.4. Implications and further research 
This study’s findings reaffirm the necessity of further diagnostic tests to 
distinguish the actual causes of diarrhoea, seeing as the symptoms exhibited are 
diverse and not usually pathogen-specific (Figure 11 and Figure 12). Since 
diarrhoea is usually treated symptomatically, exact diagnosis of the pathogen 
responsible may seem unnecessary, overly time-consuming and expensive, 
especially in low-resource settings like Gabon, yet a better understanding of the 




One preventive option already available is the rotavirus vaccine, which has been 
available since 2006 and is recommended as a routine vaccination for children 
from 2 to 8 months of age by the WHO (World Health Organization (WHO), 
2013a). This could already be implemented following this study, seeing as 
rotavirus ranked third in the list of pathogens identified in this study (Figure 8) and 
thus implies that a significant proportion of patients would have benefitted from 
early vaccination. The results presented here could function as a baseline when 
evaluating the efficacy should a national vaccination programme be implemented 
in the following years. 
Water and sanitation hygiene (WASH) 
The high coincidence of Giardia and Cryptosporidium (Figure 9) gives rise to the 
suspicion of high levels of water contamination with both parasites, seeing as 
infection with the former has been mostly linked to contaminated water sources 
and the latter has been known to cause water-borne outbreaks worldwide 
(Efstratiou et al., 2017; Fayer, 2004).  
A further step following this study would be to examine the water sources in and 
around Lambaréné. Especially considering the amount of co-infections with 
pathogens that are known or at least suspected to be sometimes transmitted 
through contaminated water, it could prove quite informing to see whether the 
respective pathogens can be found in common water sources and to see if better 
sanitation systems might lower the incidence of diarrhoea in the respective area. 
The unsolved enigma  
Diarrhoeal disease still ranks fifth in the global causes of Years of Life Lost for all 
age groups in 2017 (as opposed to third in 1990) (Roth et al., 2018) and fourth 
as the most frequent cause of death in children and adolescents globally in 2015, 
taking third place when only considering countries with a low socio-demographic 
index/SDI (Roba et al., 2017). Compared to other major causes of morbidity and 
mortality the future research targets are less tangible. The direct causes of 
pneumonia, neonatal deaths, meningitis, malaria are easier to determine and 




disease, it is shocking that this study is one of few conducted in Gabon on this 
matter, and more importantly the first of its kind in Lambaréné and its 
surroundings. Most studies in this area are still focused on malaria and 
tuberculosis. Illnesses that undisputedly cause high rates of morbidity and 
mortality but are all the same not the sole healthcare issue to be tackled. 
More comprehensive studies on the epidemiology of diarrhoea are needed, not 
only in children, but also in adults to determine if and why there is a different 
range of pathogens responsible. Rotavirus for example has long been known to 
mainly affect children, leaving them ostensibly immune in the aftermath. The high 
prevalence of infection with Cryptosporidium spp. in young children and the 
subsequent findings of many asymptomatic carriers in adults, may indicate a 
similar immune reaction.  However, immunity towards parasites, with the partial 
immunity against malaria parasites in countries with high endemicity as its most 
prominent example, is still not well understood and leaves many questions. A 
better understanding of the mechanisms involved may provide new ideas on how 
to treat and maybe even prevent infection with Cryptosporidium and possibly 







Diarrhoeal disease causes more than half a million deaths of children below five 
years of age each year, making it the third most frequent cause of child mortality 
worldwide. While much has been achieved over the last few years, there is still 
little known of the exact epidemiology of diarrheagenic pathogens due to mostly 
symptomatic treatment and subsequently infrequent testing for said pathogens. 
Recent studies have identified a different spectrum of pathogens than what had 
formerly been presumed to be responsible for most cases of diarrhoea in children 
(Kotloff et al., 2013).  
Methods 
Patients aged between 0 and 5 years of age presenting at the OPD of either one 
of the two hospitals in Lambaréné, Gabon were included, a clinical examination 
conducted, and a stool sample collected. Samples were then analysed by RDTs 
for Rota-/Adenovirus and Cryptosporidium spp., as well as Microbiological 
culture, wet mound technique and Multiplex-PCR for Cryptosporidium spp., 
Giardia int. and Cyclospora cayetanensis. 
Results 
Of the 94 samples included in the final analysis, Giardia int. was identified in 19 
samples (20%), Cryptosporidium spp. in 18 (19%), rotavirus in 14 (15%), Shigella 
spp. in 5 (5%), E.coli in 4 (4%), Cyclospora cayetanensis in 3 (3%), Taenia spp. 
in 2 (2%) and adenovirus, Ascaris lumbricoides and Plesiomonas shigelloides in 
1 sample (1%) respectively. 7 patients were found to be infected with malaria 
(7%) and 5 had measles (5%). 15 patients (16%) had more than one pathogen 
or were additionally diagnosed with either malaria or measles. No infectious agent 
could be identified for 33 patients (35%). No significant differences between 
infections identified and symptoms exhibited or incidence across seasons could 
be observed. But a significant difference in incidence was observed for 




As a side project a RDT for Cryptosporidium spp. was evaluated in comparison 
to Multiplex-PCR. This yielded a sensitivity of 88.9%, and specificity of 90.8%.  
Conclusion  
The findings of this study may be used as baseline data for further studies in this 
area, e.g., as a reference should the rotavirus vaccine be implemented to the 
national vaccination programme in Gabon, as recommended by the WHO. 
Further research needs to be conducted on transmission of different parasites 
especially Cryptosporidium spp. to implement adequate preventive measures in 
the future. Additionally, the role of Giardia int. in childhood development and 
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9. German Summary 
Hintergrund 
Weltweit sterben jedes Jahr mehr als eine halbe Millionen Kinder unter 5 Jahren 
aufgrund von Durchfallerkrankungen, welche damit den dritten Platz als Grund 
von Kindersterblichkeit belegen. Obwohl in den letzten Jahren im Hinblick auf die 
Behandlung dieser Kinder viel erreicht wurde, weiß man immer noch viel zu 
wenig über die genaue Epidemiologie der Pathogene, die Durchfall auslösen, da 
Patienten meist nur symptomatisch behandelt werden und dementsprechend 
nicht flächendeckend auf diese getestet werden. In neueren Studien wurde ein 
vollkommen neues Spektrum an Pathogenen, als bisher angenommen 
identifiziert, das in den meisten Fällen Durchfall in Kindern auslöst (Kotloff et al., 
2013). 
Methoden  
Es wurden Patienten zwischen 0 und 5 Jahren in die Studie eingeschlossen, die 
sich in der Ambulanz eines der zwei Krankenhäuser in Lambaréné, Gabun 
vorstellten. Es wurde eine klinische Untersuchung durchgeführt, ein Fragebogen 
mit den Eltern oder Sorgeberechtigten ausgefüllt und eine Stuhlprobe 
genommen. Die Proben wurden dann mittels Schnelltests für Rota-/Adenovirus 
und Cryptosporidium spp., Mikrobiologischer Kultur, Nativpräparat und Multiplex-
PCR auf Cryptosporidium spp., Giardia int. und Cyclospora cayetanensis 
untersucht.  
Ergebnisse 
94 Proben wurden abschließend ausgewertet. Dabei wurde in 19 (20%) Giardia 
int. gefunden, Cryptosporidium spp. in 18 (19%), Rotavirus in 14 (15%), Shigella 
spp. in 5 (5%), E.coli in 4 (4%), Cyclospora cayetanensis in drei (3%), Taenia 
spp. in zwei (2%), sowie Adenovirus, Ascaris lumbricoides und Plesiomonas 
shigelloides in je einer Probe (1%). 7 Patienten waren mit Malaria (7%) infiziert 
und 5 hatten Masern (5%). 15 Patienten (16%) wiesen mehr als einen 
Krankheitserreger in der Stuhlprobe auf oder wurden zusätzlich mit Malaria oder 
Masern diagnostiziert. Kein Krankheitserreger oder eine spezifische Erkrankung 
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konnte bei 33 Patienten (35%) nachgewiesen werden. Es konnte kein 
signifikanter Unterschied der verschiedenen Krankheitserreger bezüglich der 
hervorgerufenen Symptome oder der Inzidenz nach Jahreszeiten gezeigt 
werden. Es konnte aber ein signifikanter Unterschied in der Inzidenz von 
Cryptosporidium spp., Giardia int. und Rotavirus je nach Altersgruppe beobachtet 
werden. 
Als Nebenprojekt wurde ein Schnelltest für Cryptosporidium spp. im Vergleich zur 
Multiplex-PCR evaluiert, was eine Sensitivität von 88.9%, und Spezifizität von 
90.8% ergab.  
Schlussfolgerung 
Die Ergebnisse dieser Studie können als Grundlage für weitere Studien in diesem 
Bereich dienen, z.B., als Referenz falls die von der WHO empfohlene Impfung 
gegen Rotavirus in das gabunische nationale Impfprogramm aufgenommen 
werden sollte. Weitere Forschung ist nötig, was die Transmission der 
verschiedenen Parasiten, vor allem Cryptosporidium spp., angeht, damit in der 
Zukunft adäquate Präventionsmaßnahmen durchgeführt werden können. 
Außerdem muss die Rolle von Giardia int., vor allem im Hinblick auf die 
Entwicklung im Kindesalter, sowie dessen genaue Rolle bei 
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